Target Name: ALG1L1P
NCBI ID: G200810
Review Report on ALG1L1P Target / Biomarker Content of Review Report on ALG1L1P Target / Biomarker
ALG1L1P
Other Name(s): Putative glycosyltransferase ALG1-like (isoform 1) | asparagine-linked glycosylation 1-like 1 | ALG1 like 1, pseudogene | beta-1,4-mannosyltransferase-like | ALG1L1 | ALG1L_HUMAN | ALG1L variant 1 | Putative glycosyltransferase ALG1-like | ALG1L | putative glycosyltransferase ALG1-like | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like, transcript variant 1

ALG1L1P: A Protein Involved in Cell Adhesion, Migration and Insulin Secretion

ALG1L1P (Putative Glycosyltransferase ALG1-like (Isoform 1)) is a protein that is expressed in various tissues and cells in the human body. It is a member of the glycosyltransferase family 1, which is involved in the transfer of glycosidic bonds between carbohydrates. ALG1L1P is putative to be a drug target or biomarker due to its unique structure and the various functions it is involved in.

ALG1L1P is a 184-kDa protein that is expressed in the liver, spleen, and pancreas. It is localized to the endoplasmic reticulum and can be released from the endoplasmic reticulum through the secretory pathway. ALG1L1P is also known to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.

One of the unique features of ALG1L1P is its structure. It has a distinct N-terminus that is involved in protein-protein interactions and a C-terminus that is involved in carbohydrate binding. The middle region of the protein is rich in acidic amino acids, which is known to be important for the protein's stability and stability.

ALG1L1P is involved in the transfer of glycosidic bonds between carbohydrates. This process is known as glycosylation, and it is a critical step in the development and maintenance of many cellular processes. For example, ALG1L1P is involved in the glycosylation of the protein insulin, which is a hormone that regulates blood sugar levels. Insulin is synthesized in the pancreas and is released into the bloodstream to regulate the levels of glucose. ALG1L1P plays a critical role in the regulation of insulin secretion by ensuring that the insulin chain is properly glycosylated.

In addition to its involvement in insulin secretion, ALG1L1P is also involved in the regulation of cell adhesion and migration. Adhesion is the process by which cells stick together to form tissues and organs. ALG1L1P is involved in the regulation of cell adhesion by ensuring that the cell adhesion molecules are properly glycosylated. Migration is the process by which cells move from one location to another in the body. ALG1L1P is involved in the regulation of cell migration by ensuring that the cell migration molecules are properly glycosylated.

ALG1L1P is also involved in the regulation of cellular processes such as cell signaling pathways. Signaling pathways are the processes by which cells communicate with each other and with the surrounding environment. ALG1L1P is involved in the regulation of cellular signaling pathways by ensuring that the signaling molecules are properly glycosylated.

In conclusion, ALG1L1P is a unique and highly conserved protein that plays a critical role in the regulation of cellular processes. Its structure and functions make it a potential drug target or biomarker. Further research is needed to fully understand the role of ALG1L1P in the regulation of cellular processes and to develop effective treatments for the prevention and treatment of various diseases.

Protein Name: ALG1 Like 1, Pseudogene

The "ALG1L1P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALG1L1P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ALG1L2 | ALG1L5P | ALG1L7P | ALG1L8P | ALG2 | ALG3 | ALG5 | ALG6 | ALG8 | ALG9 | ALK | ALKAL1 | ALKAL2 | Alkaline Phosphatase (ALP) | ALKBH1 | ALKBH2 | ALKBH3 | ALKBH4 | ALKBH5 | ALKBH6 | ALKBH7 | ALKBH8 | ALLC | ALMS1 | ALMS1-IT1 | ALMS1P1 | ALOX12 | ALOX12-AS1 | ALOX12B | ALOX12P2 | ALOX15 | ALOX15B | ALOX15P1 | ALOX15P2 | ALOX5 | ALOX5AP | ALOXE3 | ALPG | Alpha-2 Adrenergic receptors | alpha-6 beta-2 Nicotinic receptor | alpha-Adrenoceptor | alpha-Amylase | alpha-beta T Cell Receptor Complex (TCR) | Alpha-crystallin | alpha-Mannosidase | alpha-Secretase | alpha1-Adrenoceptor | ALPI | ALPK1 | ALPK2 | ALPK3 | ALPL | ALPP | ALS2 | ALS2CL | ALX1 | ALX3 | ALX4 | ALYREF | AMACR | AMBN | AMBP | AMBRA1 | AMD1 | AMD1P2 | AMDHD1 | AMDHD2 | AMELX | AMELY | AMER1 | AMER2 | AMER3 | AMFR | AMH | AMHR2 | AMIGO1 | AMIGO2 | AMIGO3 | Amine oxidase (copper containing) | Amino acid hydroxylase | Aminoacyl-tRNA Synthetase Complex | AMMECR1 | AMMECR1L | AMN | AMN1 | AMOT | AMOTL1 | AMOTL2 | AMP Deaminase | AMP-activated protein kinase (AMPK) | AMP-activated protein kinase alpha1beta1gamma1 | AMP-activated protein kinase alpha2beta1gamma1 | AMP-activated protein kinase alpha2beta1gamma2 | AMP-activated protein kinase alpha2beta2gamma2 | AMPD1 | AMPD2 | AMPD3 | AMPH | AMT | AMTN